Evidence map›Paper›PMID 36235550›Full record

ArticleNutrients2022

Is It Possible to Improve the Bioavailability of Resveratrol and Polydatin Derived from

Magdalena Paczkowska-Walendowska, Andrzej Miklaszewski, Judyta Cielecka-Piontek

Open access · goldAbstract read
In one paragraph

Article in Nutrients, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Modulating Role of Resveratrol in Metabolic and Inflammatory Dysregulation Caused by Surgical and Psychoemotional Stress in Rats.Pathophysiology : the official journal of the International Society for Pathophysiology · 2025
    Article
  3. Review
  4. Cyclodextrin/PVP-Based Nanofibers withMolecules (Basel, Switzerland) · 2025
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Magdalena Paczkowska-WalendowskaDepartment of Pharmacognosy, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznan, Poland.ORCID 0000-0002-0418-9336
Andrzej MiklaszewskiInstitute of Materials Science and Engineering, Faculty of Materials Engineering and Technical Physics, Poznan University of Technology, Jana Pawła II 24, 61-138 Poznan, Poland.ORCID 0000-0001-6792-4281
Judyta Cielecka-PiontekDepartment of Pharmacognosy, Poznan University of Medical Sciences, Rokietnicka 3, 60-806 Poznan, Poland.ORCID 0000-0003-0891-5419
Poznan University of Medical Sciences · PLPoznań University of Technology · PL

Funding

National Science Center 2020/39/D/NZ7/01824
6 · The paper itself

Abstract

The low bioavailability of resveratrol and polydatin obtained from

Indexed as

CyclodextrinsDrugs, Chinese HerbalNanofibersStilbenesAntioxidantsBiological AvailabilityGlucosidesMethanolPovidoneResveratrolAntioxidantsCyclodextrinsDrugs, Chinese HerbalGlucosidesMethanolpolydatinPovidoneResveratrolStilbenesbioavailabilitynanofiberspolydatinPolygoni cuspidate extractresveratrol

Identifiers

PMID36235550
PMCPMC9572329
OpenAlexW4296614358

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.